Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021
State economic costs of diagnosed diabetes are substantial and increased over the last decade. These costs and their growth vary considerably across states. These findings may help state policymakers in developing evidenced-based public health interventions in their respective states to prevent and control the prevalence of diabetes.
Authors
- Olga Khavjou (ORCID: https://orcid.org/0000-0003-0805-0769)
- Kristopher Myers (ORCID: https://orcid.org/0000-0001-5631-7646)
- Simon Neuwahl (ORCID: https://orcid.org/0000-0003-3512-7397)
- Pyone Cho
- Thomas J. Hoerger (ORCID: https://orcid.org/0000-0003-4154-7806)
- Minglu Sun
- Ping Zhang (ORCID: https://orcid.org/0000-0001-8429-6301)
- Sophia R. D’Angelo (ORCID: https://orcid.org/0000-0003-4564-1058)
Institutions
- Centers for Disease Control and Prevention (US)
- RTI International (US)
- Chesapeake Public Schools (US)
- Centers for Disease Control and Prevention (UG)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-08-09
- DOI
- https://doi.org/10.2337/dc24-0832
- Citations
- 1
- Primary Topic
- Primary Care and Health Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Center for Chronic Disease Prevention and Health Promotion